APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inactivated Polio and Rabies Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Inactivated Polio and Rabies Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025183 pages

Choose your research edition.

Industry ResearchInactivated Polio and Rabies Vaccines Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Inactivated Polio and Rabies Vaccines Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Inactivated Polio and Rabies Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inactivated Polio and Rabies Vaccines Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Inactivated Polio and Rabies Vaccines Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Inactivated Polio and Rabies Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Inactivated Polio and Rabies Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inactivated Polio and Rabies Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inactivated Polio and Rabies Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Inactivated Polio and Rabies Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inactivated Polio and Rabies Vaccines include Bharat Biotech, BIO-MED, Kedrion Biopharma, Serum Institute of India, GlaxoSmithKline, Pfizer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inactivated Polio and Rabies Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inactivated Polio and Rabies Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inactivated Polio and Rabies Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inactivated Polio and Rabies Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Inactivated Polio and Rabies Vaccines Segment by Company

Bharat Biotech

BIO-MED

Kedrion Biopharma

Serum Institute of India

GlaxoSmithKline

Pfizer

Merck

Inactivated Polio and Rabies Vaccines Segment by Type

Inactivated Polio Vaccine

Inactivated Rabies Vaccine

Inactivated Polio and Rabies Vaccines Segment by Application

Pediatrics

Adults

Inactivated Polio and Rabies Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inactivated Polio and Rabies Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inactivated Polio and Rabies Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inactivated Polio and Rabies Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inactivated Polio and Rabies Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inactivated Polio and Rabies Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Inactivated Polio and Rabies Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Inactivated Polio and Rabies Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Inactivated Polio and Rabies Vaccines Industry Trends Table 2. Inactivated Polio and Rabies Vaccines Industry Drivers Table 3. Inactivated Polio and Rabies Vaccines Industry Opportunities and Challenges Table 4. Inactivated Polio and Rabies Vaccines Industry Restraints Table 5. Global Inactivated Polio and Rabies Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Inactivated Polio and Rabies Vaccines Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Manufacturers Table 9. Global Inactivated Polio and Rabies Vaccines Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Inactivated Polio and Rabies Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Inactivated Polio and Rabies Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Inactivated Polio and Rabies Vaccines Manufacturers, Product Type & Application Table 13. Global Inactivated Polio and Rabies Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Inactivated Polio and Rabies Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Inactivated Polio Vaccine Table 17. Major Manufacturers of Inactivated Rabies Vaccine Table 18. Global Inactivated Polio and Rabies Vaccines Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Inactivated Polio and Rabies Vaccines Sales by Type (2021-2026) & (K Units) Table 20. Global Inactivated Polio and Rabies Vaccines Sales by Type (2027-2032) & (K Units) Table 21. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Inactivated Polio and Rabies Vaccines Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Inactivated Polio and Rabies Vaccines Revenue by Type (2021-2026) & (K Units) Table 25. Global Inactivated Polio and Rabies Vaccines Revenue by Type (2027-2032) & (K Units) Table 26. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Pediatrics Table 29. Major Manufacturers of Adults Table 30. Global Inactivated Polio and Rabies Vaccines Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Inactivated Polio and Rabies Vaccines Sales by Application (2021-2026) & (K Units) Table 32. Global Inactivated Polio and Rabies Vaccines Sales by Application (2027-2032) & (K Units) Table 33. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2021-2026) Table 34. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2027-2032) Table 35. Global Inactivated Polio and Rabies Vaccines Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Inactivated Polio and Rabies Vaccines Revenue by Application (2021-2026) & (K Units) Table 37. Global Inactivated Polio and Rabies Vaccines Revenue by Application (2027-2032) & (K Units) Table 38. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2021-2026) Table 39. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2027-2032) Table 40. Global Inactivated Polio and Rabies Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Inactivated Polio and Rabies Vaccines Sales by Region (2021-2026) & (K Units) Table 42. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Region (2021-2026) Table 43. Global Inactivated Polio and Rabies Vaccines Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Inactivated Polio and Rabies Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Inactivated Polio and Rabies Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Inactivated Polio and Rabies Vaccines Sales by Country (2021-2026) & (K Units) Table 47. North America Inactivated Polio and Rabies Vaccines Sales by Country (2027-2032) & (K Units) Table 48. Europe Inactivated Polio and Rabies Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Inactivated Polio and Rabies Vaccines Sales by Country (2021-2026) & (K Units) Table 50. Europe Inactivated Polio and Rabies Vaccines Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Inactivated Polio and Rabies Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Inactivated Polio and Rabies Vaccines Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Inactivated Polio and Rabies Vaccines Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Country (2027-2032) & (K Units) Table 57. Global Inactivated Polio and Rabies Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Inactivated Polio and Rabies Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Inactivated Polio and Rabies Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Region (2021-2026) Table 61. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Region (2027-2032) Table 62. Bharat Biotech Company Information Table 63. Bharat Biotech Business Overview Table 64. Bharat Biotech Inactivated Polio and Rabies Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Bharat Biotech Inactivated Polio and Rabies Vaccines Product Portfolio Table 66. Bharat Biotech Recent Development Table 67. BIO-MED Company Information Table 68. BIO-MED Business Overview Table 69. BIO-MED Inactivated Polio and Rabies Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. BIO-MED Inactivated Polio and Rabies Vaccines Product Portfolio Table 71. BIO-MED Recent Development Table 72. Kedrion Biopharma Company Information Table 73. Kedrion Biopharma Business Overview Table 74. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product Portfolio Table 76. Kedrion Biopharma Recent Development Table 77. Serum Institute of India Company Information Table 78. Serum Institute of India Business Overview Table 79. Serum Institute of India Inactivated Polio and Rabies Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Serum Institute of India Inactivated Polio and Rabies Vaccines Product Portfolio Table 81. Serum Institute of India Recent Development Table 82. GlaxoSmithKline Company Information Table 83. GlaxoSmithKline Business Overview Table 84. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product Portfolio Table 86. GlaxoSmithKline Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Inactivated Polio and Rabies Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Pfizer Inactivated Polio and Rabies Vaccines Product Portfolio Table 91. Pfizer Recent Development Table 92. Merck Company Information Table 93. Merck Business Overview Table 94. Merck Inactivated Polio and Rabies Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Merck Inactivated Polio and Rabies Vaccines Product Portfolio Table 96. Merck Recent Development Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. Inactivated Polio and Rabies Vaccines Distributors List Table 100. Inactivated Polio and Rabies Vaccines Customers List Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Inactivated Polio and Rabies Vaccines Product Image Figure 2. Global Inactivated Polio and Rabies Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inactivated Polio and Rabies Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Inactivated Polio and Rabies Vaccines Sales (2021-2032) & (K Units) Figure 5. Global Inactivated Polio and Rabies Vaccines Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Inactivated Polio and Rabies Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Inactivated Polio Vaccine Image Figure 9. Inactivated Rabies Vaccine Image Figure 10. Global Inactivated Polio and Rabies Vaccines Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Inactivated Polio and Rabies Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Inactivated Polio and Rabies Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Inactivated Polio and Rabies Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Pediatrics Image Figure 17. Adults Image Figure 18. Global Inactivated Polio and Rabies Vaccines Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Inactivated Polio and Rabies Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2021-2032) Figure 21. Global Inactivated Polio and Rabies Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Inactivated Polio and Rabies Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2021-2032) Figure 24. North America Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2021-2032) Figure 26. U.S. Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2021-2032) Figure 31. Germany Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2021-2032) Figure 38. China Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Market Share by Country (2021-2032) Figure 46. Brazil Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Inactivated Polio and Rabies Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Inactivated Polio and Rabies Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Inactivated Polio and Rabies Vaccines Revenue (2021-2032) & (US$ Million) Figure 57. North America Inactivated Polio and Rabies Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Inactivated Polio and Rabies Vaccines Revenue (2021-2032) & (US$ Million) Figure 59. Europe Inactivated Polio and Rabies Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Inactivated Polio and Rabies Vaccines Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Inactivated Polio and Rabies Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Inactivated Polio and Rabies Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Inactivated Polio and Rabies Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Inactivated Polio and Rabies Vaccines Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Inactivated Polio and Rabies Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Polio Vaccine
  • Inactivated Rabies Vaccine
Applications
  • Pediatrics
  • Adults
Companies covered
  • Bharat Biotech
  • BIO-MED
  • Kedrion Biopharma
  • Serum Institute of India
  • GlaxoSmithKline
  • Pfizer
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Inactivated Polio and Rabies Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Inactivated Polio and Rabies Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Inactivated Polio and Rabies Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Inactivated Polio and Rabies Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Inactivated Polio and Rabies Vaccines Market Dynamics
  1. 2.1 Inactivated Polio and Rabies Vaccines Industry Trends
  2. 2.2 Inactivated Polio and Rabies Vaccines Industry Drivers
  3. 2.3 Inactivated Polio and Rabies Vaccines Industry Opportunities and Challenges
  4. 2.4 Inactivated Polio and Rabies Vaccines Industry Restraints
3 Inactivated Polio and Rabies Vaccines Market by Manufacturers
  1. 3.1 Global Inactivated Polio and Rabies Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Inactivated Polio and Rabies Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Inactivated Polio and Rabies Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Inactivated Polio and Rabies Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inactivated Polio and Rabies Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Inactivated Polio and Rabies Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Inactivated Polio and Rabies Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inactivated Polio and Rabies Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inactivated Polio and Rabies Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inactivated Polio and Rabies Vaccines Tier 1, Tier 2, and Tier 3
4 Inactivated Polio and Rabies Vaccines Market by Type
  1. 4.1 Inactivated Polio and Rabies Vaccines Type Introduction
  2. 4.1.1 Inactivated Polio Vaccine
  3. 4.1.2 Inactivated Rabies Vaccine
  4. 4.2 Global Inactivated Polio and Rabies Vaccines Sales by Type
  5. 4.2.1 Global Inactivated Polio and Rabies Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Inactivated Polio and Rabies Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Inactivated Polio and Rabies Vaccines Revenue by Type
  9. 4.3.1 Global Inactivated Polio and Rabies Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Inactivated Polio and Rabies Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2021-2032)
5 Inactivated Polio and Rabies Vaccines Market by Application
  1. 5.1 Inactivated Polio and Rabies Vaccines Application Introduction
  2. 5.1.1 Pediatrics
  3. 5.1.2 Adults
  4. 5.2 Global Inactivated Polio and Rabies Vaccines Sales by Application
  5. 5.2.1 Global Inactivated Polio and Rabies Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Inactivated Polio and Rabies Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Inactivated Polio and Rabies Vaccines Revenue by Application
  9. 5.3.1 Global Inactivated Polio and Rabies Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Inactivated Polio and Rabies Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2021-2032)
6 Global Inactivated Polio and Rabies Vaccines Sales by Region
  1. 6.1 Global Inactivated Polio and Rabies Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inactivated Polio and Rabies Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Inactivated Polio and Rabies Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Inactivated Polio and Rabies Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Inactivated Polio and Rabies Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Inactivated Polio and Rabies Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Inactivated Polio and Rabies Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Inactivated Polio and Rabies Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Inactivated Polio and Rabies Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Inactivated Polio and Rabies Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Inactivated Polio and Rabies Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Inactivated Polio and Rabies Vaccines Revenue by Region
  1. 7.1 Global Inactivated Polio and Rabies Vaccines Revenue by Region
  2. 7.1.1 Global Inactivated Polio and Rabies Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Inactivated Polio and Rabies Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Inactivated Polio and Rabies Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Inactivated Polio and Rabies Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Inactivated Polio and Rabies Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Inactivated Polio and Rabies Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Inactivated Polio and Rabies Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Inactivated Polio and Rabies Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Inactivated Polio and Rabies Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Inactivated Polio and Rabies Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Inactivated Polio and Rabies Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bharat Biotech
  2. 8.1.1 Bharat Biotech Company Information
  3. 8.1.2 Bharat Biotech Business Overview
  4. 8.1.3 Bharat Biotech Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bharat Biotech Inactivated Polio and Rabies Vaccines Product Portfolio
  6. 8.1.5 Bharat Biotech Recent Developments
  7. 8.2 BIO-MED
  8. 8.2.1 BIO-MED Company Information
  9. 8.2.2 BIO-MED Business Overview
  10. 8.2.3 BIO-MED Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BIO-MED Inactivated Polio and Rabies Vaccines Product Portfolio
  12. 8.2.5 BIO-MED Recent Developments
  13. 8.3 Kedrion Biopharma
  14. 8.3.1 Kedrion Biopharma Company Information
  15. 8.3.2 Kedrion Biopharma Business Overview
  16. 8.3.3 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product Portfolio
  18. 8.3.5 Kedrion Biopharma Recent Developments
  19. 8.4 Serum Institute of India
  20. 8.4.1 Serum Institute of India Company Information
  21. 8.4.2 Serum Institute of India Business Overview
  22. 8.4.3 Serum Institute of India Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Serum Institute of India Inactivated Polio and Rabies Vaccines Product Portfolio
  24. 8.4.5 Serum Institute of India Recent Developments
  25. 8.5 GlaxoSmithKline
  26. 8.5.1 GlaxoSmithKline Company Information
  27. 8.5.2 GlaxoSmithKline Business Overview
  28. 8.5.3 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product Portfolio
  30. 8.5.5 GlaxoSmithKline Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Inactivated Polio and Rabies Vaccines Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Merck
  38. 8.7.1 Merck Company Information
  39. 8.7.2 Merck Business Overview
  40. 8.7.3 Merck Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck Inactivated Polio and Rabies Vaccines Product Portfolio
  42. 8.7.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inactivated Polio and Rabies Vaccines Value Chain Analysis
  2. 9.1.1 Inactivated Polio and Rabies Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inactivated Polio and Rabies Vaccines Production Mode & Process
  6. 9.2 Inactivated Polio and Rabies Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inactivated Polio and Rabies Vaccines Distributors
  9. 9.2.3 Inactivated Polio and Rabies Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst